Re: Not good for the potential of apabetalone as a Covid-19 therapy
in response to
by
posted on
Dec 01, 2021 02:54PM
".....it seemed to me that lung damage came from other pan BET inhibitors but got no worse for the mice that had been engineered with ACE2 on APB. Did I miss something there?"
From our earlier discussion, there has not been a published study of apabetalone in a whole animal mouse model infected with SARS-Cov2.
BDAZ